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Abstract. Several chemoattractant receptors can sup- 
port agonist-induced, integrin-dependent arrest of roll- 
ing neutrophils in inflamed venules in vivo, as well as 
subsequent crawling into tissues. It has been hypothe- 
sized that receptors of the Goq-linked chemoattractant 
subfamilies, especially receptors for chemokines, may 
mediate parallel activation-dependent arrest of homing 
lymphocyte subsets. However, although several 
chemokines can attract subsets of B or T cells, robust 
chemoattractant triggering of resting lymphocyte adhe- 
sion to vascular ligands has not been observed. To 
study the biology of individual leukocyte chemoattrac- 
tant receptors in a defined lymphoid environment, 
mouse L1/2 pre-B cells and/or human Jurkat T cells 
were transfected with et (IL-8 receptor A) or 13 (MIP- 
ltx/CC-CKR-1) chemokine receptors, or with the classi- 
cal chemoattractant C5a (C5aR) or formyl peptide re- 
ceptors (fPR). All receptors supported robust agonist- 
dependent a4131 integrin-mediated adhesion of lym- 
phocytes to VCAM-1. L1/2 cells cotransfected with fPR 
and 137 integrin were also induced to bind MAdCAM-1, 
suggesting common mechanisms coupling chemoattrac- 
tant receptors to activation of distinct integrins. Adhe- 
sion was rapid but transient, with spontaneous rever- 
sion to unstimulated levels within 5 min after peak 
binding. When observed under flow conditions, et4131- 
mediated arrest occurred within seconds after initiation 
of contact and rolling of IL-8RA transfectants on a 
VCAM-1/IL-8 co-coated surface; and arrest reversed 
spontaneously after a mean of 5 min with a return to 
rolling behavior. Each of the receptors also conferred 
agonist-specific chemotaxis; however, whereas strong 
adhesion required simultaneous occupancy of many re- 
ceptors with maximal responses above the Ka, chemo- 
taxis in each case was suppressed at high agonist con- 
centrations. The findings indicate that et and 13 
chemokine as well as classical chemoattractant recep- 
tors can trigger robust adhesion as well as directed mi- 
gration of lymphoid cells, but that the requirements for 
and kinetics of adhesion triggering and chemotaxis are 
distinct, thus permitting their independent regulation. 
They suggest that the discordance between proadhesive 
and chemoattractant responses of circulating lympho- 
cytes to many chemokines may reflect quantitative as- 
pects of receptor expression and/or coupling rather 
than qualitative differences in receptor signaling. 
HODOPSIN-related Goq-linked 7 transmembrane "ser- 
pentine" receptors of the chemoattractant subfam- 
ily have been implicated in many aspects of leuko- 
cyte behavior, notably including the regulation of leukocyte 
adhesion, locomotion, and chemotaxis. This subfamily in- 
cludes classical chemoattractant receptors for formyl pep- 
tides and C5a, receptors for the emerging family of small 
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polypeptide chemoattractant cytokines, the chemokines, 
as well as a number of orphan receptors whose agonists 
and functions have yet to be defined (24, 33). Only a few 
of the receptors for the more than 30 known chemokines 
have been identified as yet, and the patterns of expression 
and cellular responses  to different leukocyte receptors are 
only now being explored. It is already apparent, however, 
that  the  leukocyte  responses  to  stimulation  through 
chemoattractant receptors can be diverse.  Stimulation of 
myeloid cells through classical chemoattractant or through 
IL-8 receptors triggers rapid activation of leukocyte inte- 
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trafficking, this is reflected in rapid arrest of neutrophils 
rolling along inflamed venules (46, 47). The same agonists, 
when applied experimentally to the extravascular space, 
can also support subsequent chemotaxis and diapedesis of 
the adherent polymorphonuclear leukocyte (17, 41). Phys- 
iologic studies of lymphocyte homing suggest that lympho- 
cytes  can  also  be  stimulated  through  pertussis  toxin- 
(PTX-) 1 sensitive receptors to adhere rapidly to oL4 and 132 
integrin ligands (4, 5). However, although several chemo- 
kines are chemotactic for subsets of circulating T  and B 
cells, the proadhesive  activity of known chemokines on 
resting lymphocytes is minimal and robust integrin activa- 
tion with rapid kinetics, comparable to those reported for 
myeloid cells (which can occur within seconds), has not 
been observed. For example, subsets of lymphocytes mi- 
grate in response to the tx chemokines interleukin 8 (2, 26, 
38) and IP-10 (44); and to the 13 chemokines RANTES (38, 
43, 44), MIP-lt~ (37, 43), MIP-113 (37, 42, 43), MCP-1 (11, 
30, 45),  and MCP-2 and -3  (30, 45),  and several chemo- 
kines can initiate uropod formation and polarization of 
lymphocytes  adherent  on  integrin  substrates  (13),  yet 
these  chemokines fail to  trigger  rapid  (within  seconds) 
binding of resting peripheral blood leukocytes (PBL) to 
integrin substrates (29, 42-44).  On the other hand, recent 
studies have shown that lymphoid cells do have the neces- 
sary machinery to respond to chemoattractant stimulation 
with robust adhesion to VCAM-1, when stimulated through 
transfected formyl peptide receptors (fPR) (22). Thus the 
discordance between chemokine chemoattractant and proad- 
hesive activities for lymphocytes might reflect a unique bi- 
ology of the chemokine receptors, or of their expression. 
Direct analyses of the biology of chemoattractant recep- 
tors is difficult in normal leukocyte populations, however, 
because of the potential for cell type-specific variations in 
responsiveness, differences in receptor levels, overlapping 
receptor expression, and promiscuity of receptor-agonist 
interactions (28, 34). 
The present study was designed to overcome these diffi- 
culties by expressing a  and 13 chemokine receptors along 
with classical chemoattractant receptors in a common lym- 
phoid cell environment. Our findings demonstrate com- 
mon  features  in  the  biology of these  diverse  receptors 
when expressed at similar levels in lymphocytes, and high- 
light several potential mechanisms for the differential reg- 
ulation of proadhesive versus chemoattractant responses 
during lymphocyte migration and positioning in vivo. 
Materials and Methods 
Engineering Signal and FLAG Peptides onto the Amino 
Terminus of Garlinked Chemoattractant Receptors 
The DNA sequences for the human CD5 signal peptide (to enhance sur- 
face expression (1, 19) and the "FLAG" (IBI-A Kodak Co., New Haven, 
CT) octapeptide were added to the 5' end of Geq-linked chemoattractant 
receptors by two sequential rounds of PCR amplification. The template 
eDNA was reverse transcribed from human PBL. The first round of PCR 
used a 5' primer of ~70 bases, which included ~1/3 of the CD5 signal pep- 
tide, all of the FLAG sequence, and 17 bp of overlap with the gene of in- 
1. Abbreviations used in this paper: fPR, formyl peptide receptors; fMLP, 
synthetic N-formyl-Met-Leu-Phe; PTX, pertussin toxin. 
terest (including the codon for the native start methionine). The second 
round of PCR amplification used a 5' primer of ~95 bases, which included 
a  NOT-1 restriction site, followed by a  translational start consensus se- 
quence (25), followed by the remaining 2/3 of the signal peptide DNA se- 
quence including 17 bases of overlap with the 5' end of the first round 
PCR product. The 3' primer for the first round was selected within the 3' 
untranslated region of the target eDNA, and the 3' primer for the second 
round was nested within that of the first round 3' primer and included an 
XBA-1 restriction site. The products of the second round of PCR were di- 
rectionally cloned into the expression vector pRc/CMV (Invitrogen, San 
Diego, CA). The primers were designed using the sequences from the fol- 
lowing  Genbank  submissions: hufPR  (M60626),  hulL-8RA  (M68932), 
huCC-CKR-1 (L09320) and hu C5aR (X58674). The FLAG octapeptide is 
only recognizable by the anti-FLAG mAb M1 (see below) if it is present 
on the absolute amino terminus of the protein chain (i.e., the mAb will not 
recognize the FLAG if it is preceded by even a single amino acid [19]). 
Thus, if a transfected cell line is recognized by the mAb M1, it indicates 
that the receptors have reached the cell surface and cleaved the signal 
peptide. 
Stable Transfection of Lll2 and Jurkat Cells 
Cells were transfected with linearized plasmid by electroporation as previ- 
ously described  (22).  Cells transfected with  "FLAGGED"  receptor  or 
huJ37 (15) in pRc/CMV were selected with 1 mg/ml G-418 (GIBCO BRL, 
Gaithersburg, MD) in complete culture medium (RPMI-1640, 10% iron- 
supplemented bovine serum). HufPR/hu137 double transfectants, were de- 
rived by further transfecting L1/2 cells previously transfected with hufPR 
in pMRB-101 (an expression vector selectable by mycophenolic acid) (22) 
with hu~7 in pRc/CMV as above. The drug-selected cells were stained 
with fluorescent antibodies to the FLAG or huot4137 surface proteins (see 
below) and sorted for high expression by flow cytometry on a FACS  sTAR 
with software (Consort-30; Becton-Dickinson, San Jose, CA). 
Fluorescent Antibody Staining 
Cells were  stained for anti-FLAG or anti-huct4137  by resuspending 106 
cells in 200 p~l of 5 p~g/ml mAbs M1 (IBI-A Kodak Co.) or ACT-1 (27), re- 
spectively, in staining medium (SM =  1  ×  PBS, 2% BSA,  1 mM CaCI:, 
1 mM MgC12, and 0.1% NAN3). After incubation on ice for 30 min, the 
cells were washed and resuspended in the same volume of a 1:50 dilution 
of phycoerythrin-conjugated goat anti-mouse IgG H&L (F(ab)2 fragment; 
JacksonImmuno Research Laboratories, West Grove, PA). Isotype con- 
trols were included for each cell type in each experiment. For anti-muct4, 
primary staining with PS/2 (32) was essentially as above, but second stage 
antibody was a phycoerythrin-conjugated goat anti-rat IgG H&L (F(ab)2 
fragment; Jackson ImmunoResearch Laboratories). Stained cells were an- 
alyzed using a FAC  scan driven by software (Cell Quest; Becton-Dickinson). 
Ligand Binding Studies 
The ligand binding properties of FLAGGED fPR were assayed using a 
fluorescein-conjugated formyl peptide as described previously (22), and 
were found indistinguishable from those of the unflagged receptor (Sklar, 
L.,  personal communication). The  binding of IL-8  was carried  out  in 
HBSS supplemented with 0.5%  BSA and 0.1% sodium azide. Receptor 
transfectants were resuspended to 107/ml and aliquots of 50 Ixl (5 ×  105) 
cells were added into Eppendorf tubes, incubated first with unlabeled IL-8 
of  various  concentrations,  then  0.1  nM  125I-labeled  IL-8  (Amersham 
Corp., Arlington Heights, IL). The final reaction vol was 200  txl. Total 
binding was carried out in the absence of unlabeled chemokines and non- 
specific binding was determined by incubating cells with radio-labeled IL-8 
in the presence of 125 nM of "cold" IL-8. After 30 min at 37°C, the cells 
were overlaid on 800 p.1 of 20% sucrose and spun at 3,000 rpm to separate un- 
bound isotope. The tubes were snap-frozen on dry-ice/ethanol and the tips 
of the tubes containing the cell pellets were cut off and counted. MIP-lct 
binding to CC-CKR-1 transfectants was measured as above, with slight 
modifications. The  binding buffer consisted of 50  mM Hepes,  1  mM 
CaCI2, 5 mM MgCI2, and 0.5% BSA. After incubation with radio-labeled 
and unlabeled MIP-la, cells were washed three times in binding buffer 
plus 0.5 M  NaC1.  The cell pellets were transferred into fresh tubes and 
counted in a gamma counter. All experiments were carried out using du- 
plicates and repeated at least three times. Scatchard plots were calculated 
by Microsoft Excel using linear curve fit. The brightness of anti-FLAG 
staining was found to be proportional to the number of receptors per cell, 
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transfectant subclones with known densities were used to create a stan- 
dard curve to convert FLAG-staining brightness to receptors per cell. 
Assay for Inducible Adhesion to VCAM-1 or 
MAdCAM-1 
Native mouse VCAM-1 and recombinant mouse MAdCAM-1 were affin- 
ity purified and coated onto 5-mm-diam wells of glass slides as previously 
described (7, 22). The coated wells were blocked with 20 p.l bovine serum 
for 15 min at 37°C in a humidified chamber. The serum was aspirated and 
105 cells added in 16 jxl complete culture medium (equilibrated at 37°C in 
8% CO2) and the cells were allowed to settle for 5 min. At various time 
points, 4 txl of 5× agonist or control was added at the 12 o'clock position 
of the well. At the appropriate time point, the slide was dipped twice (once 
in each direction) in ice-cold  HBSS/10 mM Hepes to remove nonadherent 
cells, then fixed in ice-cold  HBSS/10 mM Hepes with 1.5% gluteraldehyde 
for I h. The 0.2-mm  2 field closest to the site of addition was counted using 
video imaging software (NIH Image 5.0)  and the percentage of starting 
cells bound per field  was calculated.  Each experiment was performed in 
triplicate  for each time point and the SEM calculated.  Synthetic N-formyl- 
Met-Leu-Phe (fMLP) and recombinant human C5a  were obtained from 
Sigma Chemical Co. (St. Louis, MO). Recombinant human IL-8 and MIP-lc~ 
were obtained from R & D Systems Inc. (Minneapolis, MN). 
Determination of the Dose Response of 
Agonist-induced VCAM-I Binding 
VCAM-l-coated slides were prepared as above, but blocked with serum 
at 0°C instead of 37°C. Slides were kept at 0°C by placing them on an ice- 
cold metal block. Cells were chilled  to 0°C in a 0.5-ml tube and mixed with 
5 × agonist to a final concentration of 105 cells/20 ~1. Cells and ligand were 
incubated together on ice for 15 rain. The serum was aspirated from the 
ice-cold  slides and replaced with 20 p~l cells + agonist, which were allowed 
to settle for 5 rain. After settling,  the slides were warmed rapidly by mov- 
ing them from the 0°C metal block to a 37°C block, and incubated at 37°C 
for 2 min before washing and fixing as above (2 min was determined to be 
the time of peak adhesion in this assay; not shown). Triplicate wells were 
performed for each experiment, and four fields  (0.2 mm  2) counted per 
well. No adhesion was observed when identical  slides were kept at 0°C for 
the entire experiment (not shown). 
Interaction of lL-8RA Transfectants with VCAM-1 + 
IL-8 under Flow 
The inside  of 100-1zl "microcap" capillary  tubes (Drummond Scientific 
Co.,  Broomall, PA) were coated with muVCAM-1 and the density esti- 
mated at 100 sites/p~m  2 by radioimmunoassay  as described (6). Some areas 
of the tube were left  uncoated as a control. After coating, the unbound 
VCAM-1 was washed away and the entire inside of the capillary  blocked 
with 100% BCS at room temperature for 30 min. To co-coat the VCAM-1 
areas with immobilized IL-8 (or control), 20 p~l of 1 ~M IL-8 (in complete 
medium) was added  through the  downstream end of the capillary  and 
coaxed into the same position as the VCAM-l-coated area. Great care 
was taken that no IL-8 touched the capillary  upstream of the VCAM-1. 
The tube was incubated for 5 min at room temperature. Just before the 
experiment, the unbound IL-8 was washed out through the downstream 
end of the tube by infusing 5 ml of warm, complete medium into the up- 
stream end. Washing in this direction prevented IL-8 from contacting the 
upstream areas. The amount of IL-8 bound to the capillary by this proce- 
dure was estimated using lzsI-IL-8 (Amersham Corp.) of known specific 
activity, and found to be coated to an approximate density of 3 ×  103 mol- 
ecules per jxm  2. The presence of VCAM-1 did not affect the amount of IL-g 
bound, and perfusion of 20 p~l warm, complete medium through the capil- 
lary did not significantly  reduce the amount of IL-8 bound (not shown). 
Cells were passed through the capillary in warm, complete medium at a 
density of 2 ×  106 cells/ml. The rate of flow was controlled by a "Harvard 
33" syringe pump (Harvard Apparatus, South Natick, MA). The reported 
experiments were performed at a flow rate of 1,700 ~.l/min, which creates 
a wall shear rate of ~2.7 dynes/cm  2 for a capillary of 1.025 mm inner diam 
as calculated  from Poiseuille's law for Newtonian fluids,  with viscosity 
0.01 P.  {WSS in dynes/cm  2 =  mean flow velocity  (mm/s) ×  [8 / tube diam 
(mm)]  ×  viscosity  (P)}.  The interactions of cells  with the coated  areas 
were recorded on video tape, and the behavior of individual  cells analyzed 
frame-by-frame. 
PTX Treatment 
L1/2 IL-8RA-FLAG transfectants were suspended at a density of 2 ×  106 
cells/ml in complete medium (RPMI 1640/10% BCS) and treated with in- 
tact PTX (List Biological  Laboratories, Inc.,  Campbell, CA) or mutant 
PTX (31, 35) at 100 ng/ml for 2 h at 37°C in an 8% CO2 incubator. 
Migration Assay 
Cells  were spun down and washed in migration medium (MM  =  RPMI 
1640, 0.5% BSA (fraction V; Sigma Chemical Co.), equilibrated overnight 
in 8% CO2 at 37°C) and resuspended at 107 cells/ml in MM (or in MM + 
agonist for the checkerboard assays). Tissue-culture inserts (Collaborative 
Biomedical Products, Bedford, MA) were placed in each of the wells of 
24-well tissue-culture plates, forming an upper and lower chamber sepa- 
rated by a polyethylene terepthalate membrane bearing 3-p~m-diam pores. 
The wells were set up ahead of time with 600 p.1 of warm, equilibrated di- 
lutions of agonist or controls in MM.  One million  ceils  in 100  p.l were 
added to the upper chamber immediately after it was placed in the well 
and the cells were allowed to migrate through to the lower chamber in an 8% 
CO2, 37°C incubator for 4-5 h. The inserts were removed after migration 
and the cells in the bottom well were transferred to chilled  12  ×  75 mm 
test tubes. L1/2 and Jurkat cells were not adherent to the 24-weU plates, 
and were easily resuspended by gentle pipetting. The ceils were counted 
by mixing a predetermined number of polystyrene beads (15  fxm; Poly- 
sciences,  Inc.,  Warrington, PA)  with the cells  and running the mixture 
through the FAC  scan. The beads and cells were easily distinguishable on a 
plot of side-scatter vs. forward scatter, allowing us to calculate  the ratio of 
beads to cells and thereby calculate  the total number of cells migrated to 
the bottom well. This counting method was confirmed to accurately repre- 
sent the number of cells present by testing it with known numbers of cells 
and beads (not shown). 
Results 
Transfection of  Lymphocyte Lines 
with Serpentine Receptors 
To compare the biology of individual Geq-linked chemoat- 
tractant receptors within  a  consistent cellular context, a 
panel of stably transfected L1/2 cells was created, each line 
expressing a  different human receptor. L1/2 cells are an 
Abelson-transforrned  murine  pre-B  cell  clone  bearing 
functional levels of cell surface et4131 integrin (22), a ligand 
for the vascular cell adhesion molecule (VCAM-1).  The 
chemoattractant receptors chosen represent members of 
the classical chemoattractant (fPR [8] and C5aR [18]), the 
ct chemokine (IL-8RA [21]) and 13 chemokine (CC-CKR-1 
[34])  receptor families. L1/2 cells were suitable for trans- 
fection with these receptors, as untransfected cells did not 
respond to agonists by calcium flux, suggesting that these 
receptors were not extant on the parent line (unpublished 
data).  Additionally,  untransfected cells did  not  respond 
above background to any of these agonists in any of the 
functional  assays  discussed  below.  The  constructs  for 
transfection were engineered so that the mature receptor 
protein bears an amino-terminal peptide "FLAG," recog- 
nizable by a monoclonal antibody, which allowed transfec- 
tants to be sorted by flow cytometry. Fig. 1 shows example 
L1/2 transfectants for each of the "FLAGGED" receptors 
stained with anti-FLAG mAb-M1. 
Ligand affinity was assayed on "FLAGGED" transfec- 
125  tants using  I-human IL-8 for IL-8RA, 125I-human MIP-let 
for CC-CKR-1, and fluoresceinated formyl-Nle-Leu-Phe- 
Nle-Tyr-Lys for fPR (this peptide has an ~30-fold higher 
affinity than fMLP for fPR; Sklar, L., personal communi- 
cation), and the KdS were found to be 0.2, 10.3, and 0.4 nM, 
respectively. Thus, these FLAGGed receptors have ligand 
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Figure 1.  Anti-FLAG staining of example L1/2 cells transfected with cDNA for various FLAGGED Gcti-linked receptors. After elec- 
troporation, cells that grew in selective medium were sorted for high cell surface FLAG expression. The cell lines shown were routinely 
sorted to maintain approximately 4 x  104 to I  x  105 receptors per cell. Staining: et-FLAG mAb followed by phycoerythrin-conjugated 
a-mouse Ig second stage. Dotted lines, control vector-transfected L1/2 cells. Solid lines, receptor transfectants.  A, fPR; B, C5aR; C, IL- 
8RA; D, CC-CKR-1. 
affinities close to those reported for the unmodified recep- 
tors, indicating that the presence of the FLAG sequence 
did not prevent specific ligand binding (not shown). The 
observed Kd CC-CKR-1 (10.3  nM) is slightly higher than 
previously reported (5.1 nM) (34). This small difference (if 
real) may be due to expression in different cell types (i.e., 
lymphoid cells in our study vs. kidney cells in [34]), or due 
to  the  presence  of  the  FLAG  interfering  slightly  with 
ligand binding. C5a receptor ligand binding was not deter- 
mined. The receptor expression of transfected lines some- 
times drifted in culture, so they were routinely sorted to 
maintain between 4 ×  104 and 1 ×  105 mean receptors per 
cell (see Materials and Methods). 
Rapid Triggering of Integrin-mediated Cell Adhesion 
The panel of receptor transfectants was tested for agonist- 
mediated adhesion  in a  VCAM-1  binding assay. Briefly, 
cells were allowed to settle  on murine VCAM-l-coated 
glass and incubated with  agonist for various times, after 
which unbound cells were washed away. Bound cells were 
then fixed and counted.  As previously demonstrated for 
unfiagged fPR transfectants  (22),  L1/2  fPR-FLAG cells were 
induced  to bind VCAM-1  within  a  very short time span 
(Fig. 2 A). All of the other receptors tested were capable 
of mediating similarly rapid and robust binding responses 
in L1/2 cells when exposed to their respective ligands (Fig. 2, 
B-D). The response was quite rapid in all cases, with sig- 
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Figure 2.  Rapid and reversible agonist-induced  adhesion of L1/2 
transfectants to purified muVCAM-1. Transfectants (open squares) 
or vector controls  (open circles) were  allowed  to  settle  on  a 
VCAM-l-coated surface,  and 100 nM agonist  was added.  The 
slides were washed vigorously at the indicated  time points to re- 
move nonadherent cells. The adherent Cells were then fixed and 
counted.  Transfectants:  A, fPR;  B, C5aR;  C, IL-8RA; D, CC- 
CKR-1. Agonists: A, fMLP; B, C5a; C, IL-8; D, MIP-lct. Error 
bars show the standard error of three wells done in parallel. 
nificant increases in binding at the earliest time points ex- 
amined.  The  CC-CKR-1  and  IL-8RA  transfectants  ap- 
peared  to  reach  their  maximal binding  somewhat more 
rapidly than C5aR and fPR transfectants. However, char- 
acteristic  of  many  G  protein-mediated  effects,  all  re- 
sponses were transient, with the number of adherent cells 
declining to baseline within 5 min after the peak. Control 
transfected ceils and unstimulated  receptor transfectants 
displayed little background binding (Fig. 2, circles). In this 
system, no binding was induced in the absence of VCAM-1, 
and induced adhesion was blocked by mAbs to or4 integrin 
or VCAM-1  (not shown). Responses were inhibitable by 
PTX  treatment,  indicating  that  the  signal  is  transduced 
through a member of the Ge~  i family (20, 40) (not shown). 
Stimulation of  fPR Induces Both a4fll- and 
a4~7-mediated Adhesion 
To determine if stimulation through a chemoattractant re- 
ceptor would also trigger the integrin  a4137, L1/2  n,R cells 
were cotransfected with cDNA encoding the human 137 in- 
tegrin chain (15). Staining with the anti-oL4 mAb PS/2 (32) 
demonstrated  that  the  hu137 transfectants  maintained  a 
level of a4 expression comparable to that of the fPR-only 
transfectants (Fig. 3 B). The hu137 transfectants bound the 
mAb Act-1  (27), which recognizes human  137 in the con- 
text of ~4  (39),  suggesting  the  formation of mua4-hu137 
complexes (Fig. 3 A). MAdCAM-1 is a ligand for a4137 in- 
tegrin but not for ~4131 (7). The presence hu137 on these 
cells allowed them to respond to fMLP by binding much 
more  avidly to  MAdCAM-1  than  cells  transfected  with 
fPR  only  (Fig.  3  C).  The  increased  adhesion  to  MAd- 
CAM-1 was accompanied by a corresponding decrease in 
binding  to  VCAM-1  (Fig.  3  D).  As  ct4131 determines 
VCAM-1 binding in many settings (7, 12), this result may 
indicate that the levels of et4131 were reduced due to dis- 
placement of mu131 with expressed hu137, and that tx4137 
was not  as efficient as  tx4131 at binding  VCAM-1.  How- 
ever, the  decrease  in VCAM-1  binding  should  be inter- 
preted with caution, as it could be an artifact of the xeno- 
heterodimer. 
Dose-Response of Ligand-induced Adhesion 
The binding response of receptor transfectants to various 
concentrations of agonist was analyzed in detail. In this as- 
say, cells were mixed with agonist on ice and then allowed 
to  settle  on  ice-cold  VCAM-l-coated  slides  for  several 
min. The slides were then rapidly warmed to 37°C and in- 
cubated for 2  min before washing and  fixing the bound 
cells. 2 min was chosen because although the binding re- 
sponse was more prolonged at lower agonist concentra- 
tions  for IL-8RA transfectants,  it was the  time point  of 
peak  binding  at  all  agonist  concentrations  tested  (not 
shown).  Induction  of  maximal  VCAM-1  binding  was 
achieved at agonist concentrations above the Kd for each 
receptor, and reached a  plateau at higher concentrations 
(Fig. 4). 
Real- Time Analysis of lL-8-Induced Integrin Triggering 
in an In Vitro Flow Assay 
To  assess  more  accurately  the  time  course  of  agonist- 
induced integrin activation, an in vitro flow assay was de- 
veloped to observe individual cells from the first moment 
they encountered agonist. The inside walls of glass capil- 
lary tubes (Fig. 5) were coated with VCAM-1, cells were 
passed through the tube in warm medium, and their be- 
havior was recorded on video tape through an inverted mi- 
croscope. We have previously shown that L1/2 cells under 
similar  conditions  were  able  to  initiate  interaction  with 
VCAM-1 through surface a4131 integrin and to begin roll- 
ing slowly on this substrate (6). When passed through the 
tube at a shear rate of 2.7  dynes/cm  2, tumbling cells (i.e., 
those  noninteracting  cells  in  the  focal plane  of the  un- 
coated  inner  tube  wall)  traveled  at  a  mean  velocity of 
N2,000 ixm/s (2,094 ___ 92 p~m/s, SD =  92, n =  10 in a repre- 
sentative experiment). At this same shear rate, cells inter- 
acting with VCAM-1  (coated to a  density of N200 sites/ 
~m  2) rolled at a mean of ~3 ixm/s (3.2 _+ 0.5 I~m/s, SD = 0.5, 
n  =  19 in a representative experiment), which is a  >600- 
fold reduction in speed (Fig. 5 A). This system was used to 
assess the effect of agonist-induced  Gcq-mediated signal- 
ing on rolling cells. IL-8 was chosen as the agonist in this 
model because  of its  ability to immobilize on solid sub- 
strates (36). To observe IL-8-induced arrest, IL-8 was co- 
coated  on  areas  of the  capillary previously coated with 
VCAM-1. The immobilization of IL-8 on the glass was not 
dependent on the presence of VCAM-1, and IL-8 was not 
washed  off by medium passed through  the  tube at high 
shear (see Materials and Methods). When L1/2  (IL'8RA-FLA~) 
cells were passed through a co-coated capillary tube (Fig. 
5 B), the number of interacting cells and the time required 
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Figure 3.  Integrin-a4137  heterodimer expression and agonist-dependent MAdCAM-1 binding in hu137/fPR transfectants. (A) Anti-a4137 
heterodimer (ACT-l) staining. Dotted line, L1/2 cells transfected with fPR only. Solid line, L1/2 cells transfected with fPR and hu137. 
(B) Anti-c~4 chain (PS/2) staining. Dotted line, Isotype-matched control staining. Solid line, PS/2 staining of L1/2 cells transfected with 
fPR only. Hatched line, PS/2 staining of L1/2 cells transfected with fPR and hu137. (C and D) fMLP-induced binding of fPR-only transfec- 
rants (open circles) and fPR +  hu137 transfectants (open squares) to purified muMAdCAM-1 (C) or purified muVCAM-1 (D). Proce- 
dure as in Fig 2. Maximum binding for MAdCAM-1 was 55 cells per field, and for VCAM-1 was 495 cells per field. Error bars show the 
range of duplicates done in parallel. 
to achieve rolling speed was unaffected by the presence of 
IL-8 (i.e., the amount of time necessary for an interacting 
cell to  reduce  velocity from  1,000  ixm/s to  10  ixm/s was 
N0.3  s whether or not IL-8 was present). However, after 
achieving rolling speed in the presence of IL-8, most of the 
cells rapidly decelerated to a complete stop and remained 
at arrest for  >1  min.  Complete arrest was never seen in 
the absence of IL-8 (Fig. 5, A  and C). The mean time for 
a  rolling cell to come to complete stop was  ~4  s  (4.4 s, 
SD  =  0.9, n  =  9 in a  representative experiment). During 
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Figure 4.  Agonist dose-response curves  for VCAM-1  binding. 
Cells were mixed with the indicated  concentration of agonist (on 
ice) and allowed to settle on VCAM-1 coated wells (on ice). The 
slides were then rapidly warmed to 37°C for 2 min and washed to 
remove nonadherent cells. The adherent cells were then fixed 
and counted (1K indicates  1,000 nM). Transfectants:  A, fPR; B, 
C5aR; C, IL-8RA; D, CC-CKR-1. Agonists: A, fMLP; B, C5a; C, 
IL-8;  D, MIP-lct. Error bars show  the  standard  error of four 
fields each from three wells. Background binding was subtracted. 
No significant  induction  over background was seen for any of 
these agonists in control transfectants analyzed  in parallel  (not 
shown). 
this time, the cells traveled a mean distance of only 16 ~xm 
(16 Ixm, SD =  0.5, n  =  9 in a representative experiment) or 
approximately  a  single  L1/2  cell  diameter.  The  results 
were similar if the IL-8 was added in soluble form, exclud- 
ing the possibility that the effect was merely due to a me- 
chanical interaction between cell surface receptor and im- 
mobilized IL-8 (not shown). No shear-resistant adhesion 
was ever seen in the absence of agonist and no rolling or 
sticking  was  seen  in  the  absence  of VCAM-1  or in  the 
presence  of blocking mAbs  to  VCAM-1  or  ~4  integrin 
(not shown). The effects of IL-8 were inhibited  by PTX 
treatment, but not by a mutant toxin lacking the Goq-ADP 
ribosylation function (31, 35) (Fig. 5 C). PTX did not affect 
rolling (not shown). 
As  seen  in  the  static  VCAM-1  binding  assays,  IL-8- 
induced  VCAM-1  binding  was transient  (Fig.  5  D). The 
duration of arrest was variable, ranging from a minimum 
of 2.3 min to >10 min, with a mean of~5 min (5.0 min, SD = 
1.3, n  =  27 in a representative experiment). At the termi- 
nation of arrest, the cells began rolling again, eventually 
reaching the mean rolling speed of cells observed in the 
absence of 1L-8 (Fig. 5 B). 
Ligand Induced Migration of Receptor Transfectants 
Each  G  protein-linked  receptor studied  here  was  origi- 
nally  characterized  as  a  chemoattractant  receptor  (33). 
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Figure 5,  Immobilized IL-8 triggers rapid but transient arrest of 
IL-8RA transfectants  rolling on VCAM-1 under flow. (A and B) 
Behavior plots of lymphocytes in the flow assay. The slope of the 
line is proportional to the velocity of the cell. Behavior of a repre- 
sentative cell is shown in each plot, with the mean and SD of each 
component (i.e., velocities for no interaction (tumbling), and roll- 
ing, and duration of deceleration and arrest phases)  of the inter- 
action for (n) cells in a representative experiment indicated in 
parentheses.  (A) IL-8RA transfectants  on VCAM-1  alone.  (B) 
IL-8RA transfectants  on VCAM-1  +  immobilized  IL-8. (C) Ef- 
fect of PTX on IL-8-triggered adhesion.  Bar graph shows the 
percent of interacting cells that arrested for longer than 1 rain in a 
typical experiment. PTX inhibited  arrest but did not reduce the 
number of interacting  cells, while mutant PTX had no significant 
effect (n =  18-24 cells observed for each condition).  Results  are 
representative of four experiments performed at various  shear 
forces. (D) Duration of arrest for arresting  cells in the presence 
of immobilized IL-8 in a typical experiment (n = 27). All experi- 
ments shown were done at 2.7 dynes/cm 2, with VCAM-1 density 
estimated at 100 sites/i,m  2. 
This presented  the opportunity to ascertain whether  the 
L1/2 cell line contained  all of the necessary intracellular 
machinery to respond to a  chemotactic gradient through 
each of these receptors. Tissue culture inserts were placed 
in each of the wells of 24-well tissue culture plates, forming 
an  upper  and  lower  chamber  separated  by  a  tracked- 
etched polyethylene terepthalate membrane bearing 3 Ixm- 
diam pores. Transfectants were placed in the upper wells, 
while chemoattractants were placed in the bottom wells at 
various concentrations. After 4-5 h incubation at 37°C, the 
cells that migrated through the 3-~m pores into the bot- 
tom well were removed and counted.  L1/2 cells are five 
times larger in diameter than the pores, and there was no 
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Figure 6. Migration of FLAGGED 
Ll/2 receptor transfectants.  Tis- 
sue-culture  inserts  were  placed 
in  each of the wells of 24-weU 
tissue-culture  plates, forming an 
upper and lower chamber sepa- 
rated  by  a  membrane bearing 
3-p~m pores.  One  million  cells 
were placed in the upper cham- 
bers,  while  the  indicated  con- 
centrations  of chemoattractants 
were placed in the lower cham- 
bers.  The  number of cells  mi- 
grated  through  the  pores  was 
calculated after 4-5 h incubation 
at 37°C. Transfectants:  A, fPR; 
B,  C5aR;  C,  IL-8RA;  D,  CC- 
CKR-1.  Agonists:  A, fMLP;  B, 
C5a; C, IL-8; D, MIP-lct.  Error 
bars show the range of duplicate 
wells done in parallel. Left scale 
indicates  the  percent  of  the 
starting  population  that  mi- 
grated.  Right scale indicates the 
total  number  of cells  that  mi- 
grated into the bottom well. Re- 
sults  are  representative  of  at 
least  three  experiments  per- 
formed.  No  migration  over 
background  levels  to  any  of 
these agonists was ever observed 
in wild-type, vector-transfected, 
or  irrelevent  receptor-trans- 
fected L1/2 cells (not shown). 
significant  migration  in  the  absence  of chemoattractant. 
All of the receptors in our panel were capable of mediat- 
ing ligand-dependent migration of L1/2 cells (Fig. 6). Like 
the  VCAM-l-binding  responses,  migration  reached  its 
peak near the Ka of the receptor. Unlike the binding re- 
sponse, migration was less efficient at higher  concentra- 
tions,  forming  a  bell-shaped  chemotactic dose-response 
curve. In this system, migration was inhibited by PTX pre- 
treatment, indicating that the chemotactic signals are also 
transduced through a member of the G~  i family (20, 40) 
(not shown). 
Ligand-induced  Migration Is Direction  Dependent 
Checkerboard  analysis  was  performed  on  each  of  the 
transfectants in the panel, to distinguish  directed  migra- 
tion from ligand-induced random motion. Briefly, a given 
concentration of agonist (10 nM) was placed in the upper, 
lower, neither, or both chambers. Again, no significant mi- 
gration was observed in the absence of agonist. The largest 
responses were seen when agonist was placed in the lower 
well only, which allows formation of a chemotactic gradi- 
ent. No migration was seen when ligand was placed in the 
top  well  only,  showing  that  the  cells  could  not  migrate 
against  a  chemotactic  gradient.  However,  when  equal 
amounts  of ligand  were  placed  in  the  upper  and  lower 
wells, L1/2 cells expressing C5aR  and IL-8RA did show 
some degree of migration (Fig. 7, B and C). According to 
these  experiments,  N1/3  of  the  migration  mediated  by 
these two receptors was direction independent at 10 nM. 
The responses of L1/2 cells expressing CC-CKR-1 or fPR 
were more direction dependent, showing little or no ran- 
dom migration at this concentration (Fig. 7, A and D). 
Transfected  IL-8RA Supports Adhesion and 
Chemotaxis in Jurkat Cells 
Jurkat, a human T cell line, was also transfected with our 
"FLAGGED" IL-8 receptor construct (Fig.  8 A). In the 
absence of transfected receptor, Jurkat was not induced by 
IL-8 to bind VCAM-1 (Fig. 8 A, circles). In the transfec- 
tants, VCAM-1 binding was induced quite rapidly (Fig. 8 
B, squares). However,  the  reversibility  of  adhesiveness 
was not as rapid as seen in L1/2 cells (Fig. 1  C). IL-8RA 
was  also  capable  of mediating migration  in  Jurkat  cells 
(Fig. 8 C), with a bell-shaped curve similar to that seen in 
L1/2 (Fig. 6 C). In Jurkat, there was no direction-indepen- 
dent  component  to  IL-8-induced  migration,  suggesting 
that partial direction independence is not a general prop- 
erty of the IL-8 receptor, but depends on the cellular back- 
ground.  Like L1/2 cells, migration and adhesion induced 
through the IL-8 receptor wire were inhibited by PTX, in- 
dicating that the chemotactic signals are also transduced 
through a member of the Got  i family (not shown) (20, 40). 
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Figure 7.  Checkerboard analysis of direction  dependence of mi- 
gration.  Migration  experiments were carried out as in Fig. 6, but 
10 nM agonist  was placed in the top, bottom, neither, or both 
chambers, as indicated.  Transfectants:  A, fPR; B, C5aR;  C, IL- 
8RA; D, CC-CKR-1.  Agonists:  A, fMLP;  B, C5a;  C, IL-8; D, 
MIP-la. Error bars show the range of duplicate  wells done in 
parallel.  Results  are  representative  of  2-4  experiments  per- 
formed. The amount of induced  random migration (i.e., in the 
top + / bottom + wells) among IL-8RA-transfected sublines was 
more variable than that of the other receptors, ranging from 10 to 
50% of maximal migration (not shown). 
Discussion 
Comparison of the biological properties of different Goq- 
linked receptors has been difficult because they are often 
expressed at different receptor densities per cell in vivo, 
making it impossible to distinguish qualitative from quan- 
titative  differences  (14).  Additionally,  especially  in  the 
case of chemokines, agonists can bind more than one re- 
ceptor, making it difficult to determine which receptor is 
involved in a given effect (28, 34). In this paper, we used a 
transfection system (in which  known  receptors were ex- 
pressed  individually  and  at comparable densities)  to ex- 
plore the biology of leukocyte serpentine chemoattractant 
receptors in a common cell host. Our findings demonstrate 
that the ability to trigger rapid, robust integrin activation 
in lymphocytes, as well as the ability to mediate chemo- 
taxis, are shared properties of receptors representing both 
and 13 chemokine, and classical chemoattractant recep- 
tor families. Although some of these Gai-linked receptors 
are not normally expressed on lymphocytes, they are all 
capable of interacting with the signal transduction machin- 
ery present within transfected lymphoid cells, and of trans- 
ducing productive signals. 
We focused initially on proadhesive responses to recep- 
tor stimulation. Each of the transfected receptors was ca- 
pable of mediating agonist-dependent integrin  activation 
in static assays involving triggering of et4131 integrin bind- 
ing  to  VCAM-l-coated  surfaces.  In  general,  significant 
binding was observed at very early time points, reaching a 
peak 1-3 min after exposure to agonist, and dropping off 
to background at later time points. The doses of agonist 
required to trigger binding were near or above the Kd of 
each receptor, and the dose-response curve reached a pla- 
teau at higher concentrations. The responses were not re- 
stricted to a4~l integrin alone, as binding to MAdCAM-1 
was  also  inducible  when  receptor  transfectants  were 
cotransfected with the f37 integrin gene. The Jurkat human 
T cell line was also capable of agonist-dependent integrin- 
mediated VCAM binding when transfected with the IL-8 
receptor A, demonstrating that the observed effects were 
not unique to the L1/2 background. High numbers of occu- 
pied receptors per cell (requiring high receptor expression 
levels more comparable to those  of chemoattractant  re- 
ceptors  on  neutrophils  rather  than  receptor  expression 
levels for those of the known chemokines on lymphocytes) 
appear to be important  for rapid  integrin  activation,  as 
transfectants  with  <10,000  receptors  did  not  undergo 
rapid adhesion in our assay, but were capable of chemot- 
axis (unpublished data). 
To  assess  the  rate  of adhesion  triggering  more  accu- 
rately, we turned to an in vitro flow assay. By comparing 
the  behavior  of  cells  encountering  VCAM-1  alone  vs. 
VCAM-1 +  IL-8-coated surfaces, we were able to observe 
directly the  consequences  of adhesion  triggering  in  real 
time.  Upon  interaction  with  VCAM-1,  a  typical  L1/2 
transfectant  moving  under  shear  and  at  high  speed  re- 
duced its velocity >600-fold, after which it maintained a con- 
stant rolling speed indefinitely. In contrast, upon interac- 
tion of transfected L1/2 cells with a combination of IL-8 and 
VCAM-1, the same cells came to a complete stop, and re- 
mained at rest for several minutes. The response was ex- 
tremely rapid, allowing the cell to roll a mean of only ~16 
ixm (roughly one L1/2 cell diameter) before halting. The 
extremely rapid adhesion and arrest was not mediated by 
IL-8 receptor-ligand binding per se, but required signaling 
through the receptor, as PTX blocked arrest but not roll- 
ing. Moreover, similarly rapid adhesive triggering was ob- 
served when IL-8 was superfused over transfectants roll- 
ing on VCAM-1 (although in this case the measurement of 
time of exposure to agonist was less precise, not shown). 
This is the first demonstration that G  protein-linked re- 
ceptors can trigger lymphocyte et4 integrin-mediated  ar- 
rest with strength  and kinetics consistent with those ob- 
served during physiologic lymphocyte-EC interactions in. 
vivo (4, 5). 
A  consistent feature of firm adhesion triggered through 
the transfected receptors was its reversibility over minutes. 
The mechanism for spontaneous reversion of integrin acti- 
vation  following  triggering  through  chemoattractant  re- 
ceptors is unknown, although it may involve desensitization 
of the chemoattractant receptor and/or active mechanisms 
of downstream feedback with integrin  deactivation.  It is 
unlikely that receptor intemalization is responsible for this 
rapid reversal, as most of the receptors still remain on the 
cell surface at the 5-min time point when most of the cells 
have already deadhered (Campbell, J., and E.C. Butcher, 
unpublished  data).  However, it is possible that receptor 
phosphorylation by GRKs may be involved in this rapid 
deactivation, as is the case in the  132-adrenergic receptor 
system  (23).  It  seems  likely  that  multiple  intracellular 
mechanisms may enforce the transience of integrin activa- 
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Figure 8.  Jurkat cells transfected with the FLAGGED IL-8RA construct respond in VCAM-1 binding and migration assays. (A) Anti- 
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in Fig. 7. (D) Migration dose response as in Fig. 6. Untransfected Jurkat cells did not respond over background to IL-8 in any of these 
assays. 
tion on lymphoid cells, to ensure their continued motility 
and responsiveness to changes in local microenvironmen- 
tal stimuli. 
Each  of the  transfected receptors also supported  ago- 
nist-directed  migration  of L1/2  cells.  The dose-response 
curve for migration reached a peak near or just above the 
reported  Kd  for  receptor-ligand  binding  and  fell  off at 
higher and lower concentrations, forming a classical bell- 
shaped  profile.  Checkerboard  analysis  established  that 
most of the migration was direction dependent. However, 
signals through C5aR and IL-8RA did trigger a significant 
level of random migration. IL-8RA-induced migration of 
Jurkat transfectants was purely direction dependent, indi- 
cating that the direction-independent  component seen in 
L1/2 cells was not solely due to the IL-8RA, but also de- 
termined by the cellular context. 
We were particularly interested in comparing and con- 
trasting the requirements for robust adhesion vs. chemo- 
taxis.  The  most  obvious  differences  between  these  two 
processes  are  their  distinct  kinetics.  The  transience  of 
strong adhesion may insure that lymphocytes do not be- 
come irreversibly stuck to cells or matrix components ex- 
pressing  chemoattractants.  In  the  context  of  leukocyte 
trafficking, for example, the transience of leukocyte arrest 
on endothelium, modeled here in the flow system, would 
argue that adherent lymphocytes would either be released 
eventually to return to the circulation, or would be freed 
to  respond  to  chemoattractant  or  haptotactic  gradients 
leading to diapedesis. Such a mechanism may ensure the 
integrity  of the  sequential,  multi-step process  of leuko- 
cyte-endothelial  interaction  and  recruitment  (9).  After 
leaving the circulation, it seems unlikely that lymphocytes 
would often encounter the rapid exposure to high concen- 
trations of soluble agonists required for strong adhesion in 
the context of cell-cell interactions  within  tissues.  How- 
ever, certain chemoattractants (e.g., the chemokines) may 
be presented at high concentrations on the surface of cells 
through  association  with  specialized  chemokine-binding 
glycosaminoglycans (42). Under such conditions, a crawl- 
ing leukocyte could be triggered by localized agonist to ad- 
The Journal of Cell Biology, Volume 134, 1996  264 here strongly to the presenting cell or matrix component. 
The effect of this would be to focus initial cellular interac- 
tions, but the transience of induced adhesion would ensure 
the  requirement  for  additional  mechanisms  regulating 
continued interaction, or in the  absence  of such stimuli 
would allow subsequent further locomotion. 
Another distinction emphasized by our results relates to 
the  receptor  occupancy  requirements  for  adhesion  vs. 
chemotactic responses. As mentioned previously, the effi- 
ciency of integrin triggering plateaued at agonist concen- 
trations higher than the Kd for each of the receptors. In 
contrast, the efficiency of chemotaxis fell off sharply at ag- 
onist concentrations higher than that required for peak ac- 
tivity. The differences between these dose-response curves 
suggest a  mechanism whereby triggered strong adhesive 
responses  and  locomotion  may  be  regulated  indepen- 
dently as a function of agonist concentration. This ability 
may be important for increasing potential combinatorial 
diversity and specificity in lymphocyte trafficking, by al- 
lowing independent control of vascular arrest and subse- 
quent chemoattractant-dependent diapedesis. In support 
of  this  idea,  preliminary  data  indicate  that  leukocytes 
bearing multiple chemoattractant receptors  can respond 
to one chemoattractant in the presence of a high adhesion- 
triggering and subsequently desensitizing dose of another 
chemoattractant (Campbell, J.J., E.G. Flescher, and E.C. 
Butcher, unpublished data). This ability may also be im- 
portant in controlling cell-cell interactions and positioning 
within the lymphoid tissue and inflammatory microenvi- 
ronments. 
Several chemokines, including IL-8 (2, 26, 38), MIP-la 
(37, 43), MIP-I[3 (37, 42, 43), RANTES (38, 43, 44), IP-10 
(44), MCP-1 (11, 30, 45), and MCP-2 and -3 (30, 45) can in- 
duce chemotaxis of human lymphocytes, and several of the 
above can trigger formation of uropod structures and cell 
polarization  in  lymphocytes  adherent  to  integrin  sub- 
strates  (13).  A  subset  of these  chemokines also  induce 
binding of lymphocytes to integrin ligands (e.g., MIP-la 
[29, 43], MIP-I[3 [29, 42, 43], IP-10 [29, 44], and RANTES 
[29, 43, 44]). However, these binding responses were mea- 
sured a minimum of 15 min (29, 42) to 1 h  (43, 44) after 
stimulation, time points well beyond the rapid responses 
studied here. Such delayed adhesion may have different 
signaling requirements. Moreover, in most instances such 
in vitro chemokine-induced lymphocyte binding responses 
appear  to require  additional cellular activation, such  as 
overnight treatment with cross-linked t~CD3 (43, 44), sug- 
gesting that chemokine-stimulated adhesion of this type 
may be more relevant to the behavior of blasts rather than 
the majority of circulating lymphocytes. Thus, no chemo- 
kines have yet been demonstrated to trigger rapid adhe- 
sion of resting lymphocytes, and it therefore seems un- 
likely that  known  chemokines  play  the  critical  role  in 
inducing the  rapid  arrest  of circulating lymphocytes on 
HEV, or in vascular sites of inflammation observed in vivo 
(4, 5). Our results, however, suggest that the discordance 
between  chemoattractant and  proadhesive  responses  of 
circulating lymphocytes to chemokines may reflect quanti- 
tative  aspects  of  receptor  expression  and/or  coupling 
rather than qualitative differences in receptor-to-integrin 
signaling. The ability of each receptor studied here to sup- 
port adhesion triggering as well as chemotaxis when ex- 
pressed at high levels, however, leaves open the possibility 
that  novel  chemokines,  perhaps  acting  through  more 
highly expressed receptors, will fulfill the promise of regu- 
lating the  rapid  adhesion-triggering step  of lymphocyte 
trafficking.  Equally  likely is  the  possibility that  novel, 
nonchemokine chemoattractants  may be  involved,  per- 
haps  acting  through  highly  expressed  receptors  of  the 
chemoattractant receptor subfamily. Particularly intrigu- 
ing in this context are recent reports of several orphan re- 
ceptors, related to the known chemoattractant and chemo- 
kine receptors, that are expressed at high levels by subsets 
of B or T lymphocytes (16, 33). 
We conclude that members of the et and 13 chemokine 
and classical chemoattractant subfamilies of Gtxi-linked re- 
ceptors can couple efficiently to integrin-activating signal- 
ing pathways in lymphocytes, as well as support chemo- 
taxis.  Most  importantly,  our  results  indicate  that  the 
distinctive receptor occupancy requirements and kinetics 
of adhesion and chemotaxis responses may permit inde- 
pendent control of these distinct events during lymphocyte 
trafficking and microenvironmental localization in vivo. 
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